Penumbra (NYSE:PEN) announced today that it received CE mark for its RED reperfusion catheter and began its European launch.
Alameda, California-based Penumbra designed its RED reperfusion catheter for the removal of all clot types in acute ischemic stroke (AIS) patients. Recent data presented by the company demonstrated successful revascularization using the RED system.
Get the full story at our sister site, Medical Tubing & Extrusion.